APA (7th ed.) Citation

Bao, Y., Rong, W., Zhu, A., Chen, Y., Chen, H., Hong, Y., . . . Wu, X. (2023). Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction. Pharmaceutics, 15(9), 2311. https://doi.org/10.3390/pharmaceutics15092311

Chicago Style (17th ed.) Citation

Bao, Yongjie, et al. "Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction." Pharmaceutics 15, no. 9 (2023): 2311. https://doi.org/10.3390/pharmaceutics15092311.

MLA (9th ed.) Citation

Bao, Yongjie, et al. "Retinoic Acid Receptor Is a Novel Therapeutic Target for Postoperative Cognitive Dysfunction." Pharmaceutics, vol. 15, no. 9, 2023, p. 2311, https://doi.org/10.3390/pharmaceutics15092311.